Asthma Clinical Trial
Official title:
AsthMaP 2: Vitamin D, Steroids, and Asthma in African American Youth
Asthma has become considerably more prevalent and severe in the U.S. during the last 40
years, particularly affecting youth in urban areas, yet the reasons for this are not clear.
There is increasing evidence that vitamin D insufficiency contributes to more severe asthma
through increased risk of respiratory infections and decreased sensitivity to
glucocorticoids. Indeed, low vitamin D levels are linked with the need for exogenous
glucocorticoids and increased asthma severity. Particularly relevant to health disparities,
we showed a strong association between vitamin D insufficiency and asthma in urban African
American (AA) youth. Importantly, AA youth in ours and other studies had lower vitamin D
levels than non-AA participants.
Because AA youth residing in urban Washington, DC have markedly worse asthma than other
racial/ethnic groups (e.g. prevalence rate 20% higher than the national rate 15 and emergency
department utilization rates up to 5 times the national rates and nearly 10 times the Healthy
People 2010 target rate), we will utilize our access to this population at the extreme of
asthma disparities to examine the contribution of vitamin D to disparities in the chronic
control and acute severity of asthma. The overall goal of this study is to provide critical
epidemiological/molecular information that will inform the interpretation of ongoing and
impending randomized clinical trials of vitamin D supplementation in asthma, especially with
regard to urban AA youth with asthma. We hypothesize that low serum 25-hydroxyvitamin D
[25(OH)D] levels are associated with poor chronic asthma control, worse acute asthma
severity, and glucocorticoid insensitivity. The knowledge generated by the experiments in
this application will be crucial to translation of this inexpensive, easily-accessible, and
thereby potentially disparity-reducing prospective therapy for asthma.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|